Breaking News
18 minutes ago
Team Pharma Now
Pharma Now releases Voices of Pharma podcast with GSK veteran Shyam Khante sharing leadership lessons, 5 pillars, and pharma transformation insights.
Team Pharma Now
Rhythm Pharmaceuticals appoints Kim Popovits to its Board as Ed Mathers steps down, strengthening leadership with commercialization expertise in rare neuroendocrine diseases.
Simantini Singh Deo
Denali Therapeutics takes full control of DNL593 after Takeda exits collaboration, advancing progranulin therapy for frontotemporal dementia with Phase 1/2 results expected by 2026.
Simantini Singh Deo
Abeona Therapeutics expands ZEVASKYN access with new Qualified Treatment Center in New York, supporting gene therapy delivery for epidermolysis bullosa patients
Simantini Singh Deo